期刊文献+

磷酸二酯酶Ⅲ抑制药的临床应用及进展 被引量:48

下载PDF
导出
摘要 磷酸二酯酶Ⅲ抑制药是正性肌力药,对急性、重度心力衰竭有一定的短期效应,但对慢性心力衰竭是不利的。近年的研究表明,通过减少药物的剂量可以明显提高其有效性和安全性。该文对以米力农为代表的磷酸二酯酶Ⅲ抑制药的临床研究进展作一概述,为临床应用提供参考。
出处 《新医学》 北大核心 2006年第10期677-679,共3页 Journal of New Medicine
  • 相关文献

参考文献11

  • 1徐淑云.中华临床药物学[M].北京:人民卫生出版社,2003.594.
  • 2严晓伟,邓华,林沁,焦镇,游凯.米力农单次静脉注射在重度心力衰竭患者的药代动力学[J].中国临床药理学杂志,2001,17(1):15-18. 被引量:5
  • 3李为民,李悦,徐岩松,吴铭,孙薇.磷酸二酯酶抑制剂(米力农)对左室功能和机械效率影响的研究[J].黑龙江医学,2001,25(1):1-2. 被引量:6
  • 4ALBRECHT C A, GIESLER G M, KAR B, et al.Intravenous milrinone infusion improves congestive heart failure caused by diastolic dysfunction: a briefcase series[J].Tex Heart Inst J, 2005, 32 (2): 220-223.
  • 5FELKER G M, BENZA R L, CHANDLER A B, et al. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study [J].J Am Coll Cardiol, 2003, 41 (6) : 997-1003.
  • 6BAYRAM M, DE LUCA L, MASSIE M B, et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes[J].Am J Cardiol, 2005, 96 (6A): 47G-58G.
  • 7吕茂家.米力农治疗重度充血性心力衰竭疗效观察[J].中西医结合心脑血管病杂志,2004,2(1):12-13. 被引量:3
  • 8SONODA K, IKEDA S, MIYAHARA Y, et al. Successful treatment of chronic pulmonary thromboembolism by long-term intermittent administration of milrinone, a phosphodiesterase inhibitor[J].Intern Med, 2002.41 (11): 961-966.
  • 9LOWES B D, TSVETKOVA T, EICHHORN E J, et al . Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol[J]. Int J Carcliol, 2001, 81 (2-3) : 141-149.
  • 10ARANDA J M, SCHOFIELD R S, PAULY D F. et al. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial [J ]. Am Heart J.2003, 145 (2): 324-329.

二级参考文献12

  • 1严晓伟,游凯,蓝志强,王子时.米力农不同剂量单次静脉注射对心力衰竭患者血液动力学的效应[J].中国循环杂志,1995,10(2):83-86. 被引量:14
  • 2李为民,Michiya Ohno,Che-Ping Cheng,黄永麟,高黎平,郭小兵.缓激肽对左室收缩和舒张功能作用的实验研究[J].中华心血管病杂志,1996,24(3):219-221. 被引量:2
  • 3[1]Evans D B.Overview of cardiovascular physiologic and pharmacologic aspect of selective phosphodiesterase peak Ⅲ inhitors[J].Am J Cardiol, 1989,63:9A.
  • 4[2]Krams R,McFalls E,Giessen W J.et al.Dose intravenous milrinone have a direct effect on diastolic function?[J]Am Heart J ,1991,121:1951.
  • 5[3]Packer M,Carver J R,Rodeheffer R J,et al.Effect of oral milrinone on mortality in sever chronic heart failure[J].N Engl J Med,1991,325:1468.
  • 6Weimin Li,Michiya.Effect of Bradykinin on left ventricle Systolic and Diast olic Performance[J].Circulation,1994,90:3191~3191.
  • 7Ohte N,Cheng CP.The cardiac effect of pimobendan (but not amrinone) are pre served at rest and during exercise in conscious dogs with pacing-induced heart f ailure[J].J.Phar.Exp.Thera,1997,282:23~31.
  • 8Nozawa T,Cheng CP,Noda T.et al.The relation between left ventricular ox ygen consumption and pressure-volume area in conscious dogs[J].Circulation,1994,89 :810~817.
  • 9Little WC,Cheng CP.Effect of exercise an left ventricular-arterial coupling assessed in the pressure-volume plane[J].Am.J.Physiol,1993,264:1629~1633.
  • 10Cheng CP,Yuichiro I,Igarashio H,et al.Effect of vasopression on left ve ntricular performance[J].Am.J.Physiol,1993,264:53~60.

共引文献31

同被引文献234

引证文献48

二级引证文献234

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部